Versant Venture Capital IV L.P. 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-09-18 5:05 pm Sale | 2020-09-09 | 13D | CRISPR Therapeutics AG CRSP | Versant Venture Capital IV L.P. | 2,087,120 3.000% | -165,136 (-7.33%) | Filing |